전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article


References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68: 394-424.
    Pubmed CrossRef
  2. Lembo D, Donalisio M, Rusnati M, Bugatti A, Cornaglia M, Cappello P, et al. 2008. Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus. Antimicrob. Agents Chemother. 52: 1374-1381.
    Pubmed PMC CrossRef
  3. Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, et al. 2017. Cervical cancer: A global health crisis. Cancer 123: 2404-2412.
    Pubmed CrossRef
  4. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. 2011. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int. J. Cancer 128: 927-935.
    Pubmed CrossRef
  5. Donalisio M, Rusnati M, Civra A, Bugatti A, Allemand D, Pirri G, et al. 2010. Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses. Antimicrob. Agents Chemother. 54: 4290-4299.
    Pubmed PMC CrossRef
  6. Stanley MA. 2012. Genital human papillomavirus infections: current and prospective therapies. J. Gen. Virol. 93: 681-691.
    Pubmed CrossRef
  7. Moscicki AB. 2005. Impact of HPV infection in adolescent populations. J. Adolesc. Health 37: S3-9.
    Pubmed CrossRef
  8. Wang SX, Zhang XS, Guan HS, Wang W. 2014. Potential anti-HPV and related cancer agents from marine resources: an overview. Mar. Drugs 12: 2019-2035.
    Pubmed PMC CrossRef
  9. Cha MK, Lee DK, An HM, Lee SW, Shin SH, Kwon JH, et al. 2012. Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16. BMC Med. 10: 72.
    Pubmed PMC CrossRef
  10. Underwood MR, Shewchuk LM, Hassell AM, Phelps WC. 2000. Searching for antiviral drugs for human papillomaviruses. Antivir. Ther. 5: 229-242.
  11. Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE, et al. 2003. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur. J. Cancer Prev. 12: 383-390.
    Pubmed CrossRef
  12. Fradet-Turcotte A, Archambault J. 2007. Recent advances in the search for antiviral agents against human papillomaviruses. Antivir. Ther. 12: 431-451.
  13. Lee BH, Chathuranga K, Uddin MB, Weeratunga P, Kim MS, Cho WK, et al. 2017. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state. J. Microbiol. 55: 488-498.
    Pubmed CrossRef
  14. Iljazovic E, Ljuca D, Sahimpasic A, Avdic S. 2006. Efficacy in treatment of cervical HRHPV infection by combination of beta interferon, and herbal therapy in woman with different cervical lesions. Bosn. J. Basic Med. Sci. 6: 79-84.
    Pubmed PMC CrossRef
  15. Polansky H, Itzkovitz E, Javaherian A. 2017. Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus. Drug Des. Devel. Ther. 11: 575-583.
    Pubmed PMC CrossRef
  16. Miyoshi N, Tanabe H, Suzuki T, Saeki K, Hara Y. 2020. Applications of a standardized green tea catechin preparation for viral warts and human papilloma virus-related and unrelated cancers. Molecules 25: 2588.
    Pubmed PMC CrossRef
  17. Ha TKQ, Lee BW, Nguyen NH, Cho HM, Venkatesan T, Doan TP, et al. 2020. Antiviral activities of compounds isolated from pinus densiflora (Pine Tree) against the influenza A Virus. Biomolecule 10: 711.
    Pubmed PMC CrossRef
  18. Zou K, Zhao Y, Tu G, Cui J, Jia Z, Zhang R. 2000. Two diastereomeric saponins with cytotoxic activity from Albizia julibrissin. Carbohydr. Res. 324: 182-188.
    CrossRef
  19. Buck CB, Pastrana DV, Lowy DR, Schiller JT. 2004. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 78: 751-757.
    Pubmed PMC CrossRef
  20. Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, FitzGerald PC, et al. 2004. Reactivity of human sera in a sensitive, highthroughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321: 205-216.
    Pubmed CrossRef
  21. Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC, Schiller JT, et al. 2008. Arrangement of L2 within the papillomavirus capsid. J. Virol. 82: 5190-5197.
    Pubmed PMC CrossRef
  22. Buck CB, Thompson CD. 2007. Production of papillomavirus-based gene transfer vectors. Curr. Protoc. Cell Biol. Chapter 26: Unit 26.1.
    Pubmed CrossRef
  23. Johnson KM, Kines RC, Roberts JN, Lowy DR, Schiller JT, Day PM. 2009. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J. Virol. 83: 2067-2074.
    Pubmed PMC CrossRef
  24. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT. 2005. Maturation of papillomavirus capsids. J. Virol. 79: 2839-2846.
    Pubmed PMC CrossRef
  25. Conway MJ, Alam S, Ryndock EJ, Cruz L, Christensen ND, Roden RB, et al. 2009. Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J. Virol. 83: 10515-10526.
    Pubmed PMC CrossRef
  26. Lee HJ, Hur YK, Cho YD, Kim MG, Lee HT, Oh YK, et al. 2012. Immunogenicity of bivalent human papillomavirus DNA vaccine using human endogenous retrovirus envelope-coated baculoviral vectors in mice and pigs. PLoS One 7: e50296.
    Pubmed PMC CrossRef
  27. Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, et al. 2007. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 13: 857-861.
    Pubmed CrossRef
  28. Longet S, Schiller JT, Bobst M, Jichlinski P, Nardelli-Haefliger D. 2011. A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection. J. Virol. 85: 13253-13259.
    Pubmed PMC CrossRef
  29. Singh O, Garg T, Rath G, Goyal AK. 2014. Microbicides for the treatment of sexually transmitted HIV Infections. J. Pharm. (Cairo). 2014: 352425.
    Pubmed PMC CrossRef
  30. Calagna G, Maranto M, Paola C, Capra G, Perino A, Chiantera V, et al. 2020. Secondary prevention' against female HPV infection: literature review of the role of carrageenan. Expert Rev. Anti. Infect. Ther. 18: 865-874.
    Pubmed CrossRef
  31. Lee C. 2020. Carrageenans as broad-spectrum microbicides: currentstatus and challenges. Mar. Drugs 18: 435.
    Pubmed PMC CrossRef

Related articles in JMB

More Related Articles